The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

Results from a case series identified a potential association between ophthalmic complications and the rapid correction of hyperglycemia, brought on by patients using either semaglutide or tirzepatide ...

Ozempic becomes the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease The Food and Drug ...

Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone ...

Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...

The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

The convenience of GetSimpli Oral Semaglutide cannot be overstated. Unlike traditional weight loss medications that often require painful injections, this product comes in a user-friendly ...

Semaglutide exposure was significantly associated with a higher incidence rate and independently predicted a higher risk for upcoming nonarteritic anterior ischemic optic neuropathy. HealthDay ...

Mounjaro comes as a solution inside injection pens that you’ll administer ... Be sure to ask your doctor or pharmacist for a demonstration of how to inject the medication. A caregiver could ...

The active ingredient in Wegovy is semaglutide. The drug comes as an injection under your skin that you give yourself in your abdomen, thigh, or upper arm. Keep reading to learn about the common ...